{
 "Susceptible": {
 "Drug": {
 "Ceftazidime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Male" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "Surgery General" ],
"percentage": [       50,       50 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Peritoneal", "GI: Other" ],
"percentage": [       50,       50 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
},
"Levofloxacin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       20,       80 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       60,       40 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "Surgery General" ],
"percentage": [       20,       80 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Peritoneal", "GI: Other" ],
"percentage": [       20,       80 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
},
"Minocycline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       20,       80 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       60,       40 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "Surgery General" ],
"percentage": [       20,       80 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Peritoneal", "GI: Other" ],
"percentage": [       20,       80 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
} 
},
"percentage": [ 16.66667, 41.66667, 41.66667 ],
"weight":      0.8,
"backgroundColor": [ "#fdbf6f", "#8dd3c7", "#80b1d3" ] 
},
"Intermediate": {
 "Drug": {
 "Ceftazidime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Male" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "Surgery General" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Other" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
} 
},
"percentage":      100,
"weight": 0.06666667,
"backgroundColor": "#fdbf6f" 
},
"Resistant": {
 "Drug": {
 "Ceftazidime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       50,       50 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "Surgery General" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Other" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
} 
},
"percentage":      100,
"weight": 0.1333333,
"backgroundColor": "#fdbf6f" 
} 
}
